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Introduction
In epithelia, biogenesis and maintenance of cell–cell adhesions 
is a highly organized process that influences cell morphology, 
initiates polarity, and supports tissue functions. Maintenance   
of cadherin-dependent junctions between neighboring cells is 
fundamental  to  ensure  epithelial  cell  differentiation  during   
morphogenesis and tissue homeostasis (Wirtz-Peitz and Zallen, 
2009). Conversely, regulatory circuits that modulate junction 
dynamics can go awry during pathogen invasion, inflammation, 
epithelial–mesenchymal conversion, and tumor progression 
(Tanos and Rodriguez-Boulan, 2008). Understanding the mech-
anisms via which junctions are stabilized may provide insights 
into therapeutic strategies to maintain an epithelial phenotype.
Adhesive E-cadherin receptors provide a platform for as-
sembly of macromolecular complexes containing cytoskeletal 
proteins, actin filaments, and signaling molecules (Braga and 
Yap, 2005). E-cadherin adhesion triggers specific actin remod-
eling that enables cell shape changes and stabilization of receptors 
at junctions (Braga, 2002; Braga and Yap, 2005; Zhang et al., 
2005; Mège et al., 2006). Yet, the precise mechanisms leading 
to local actin reorganization at cell–cell contacts and the reper-
toire of regulatory proteins involved remain unclear.
A signaling pathway important for junction-dependent 
actin remodeling is triggered by the small GTPase Rac1 (referred 
as Rac hereafter), which coordinates cadherin–F-actin associ-
ation at the plasma membrane. Rac mediates recruitment of 
actin  to  clustered  cadherin  complexes  (Braga  et  al.,  1997; 
Takaishi et al., 1997; Nakagawa et al., 2001; Lambert et al., 
2002) and the maintenance of cadherins at mature cell–cell 
contact sites (Braga et al., 1999). Rac is activated by newly 
formed cell–cell adhesion sites (Nakagawa et al., 2001; Betson 
et al., 2002) and its local activation at contacting membranes 
triggers initiation, expansion, and consolidation of cell–cell ad-
hesion (Yamada and Nelson, 2007). Force measurements re-
veal that the strength of cadherin-mediated contacts increases 
with time in an actin cytoskeleton–dependent manner and 
under the control of Rac (Lambert et al., 2002; Chu et al., 2004). 
However, how Rac activity is regulated at cadherin-dependent 
M
aintenance  of  stable  E-cadherin–dependent   
adhesion is essential for epithelial function. The 
small GTPase Rac is activated by initial cad-
herin clustering, but the precise mechanisms underlying 
Rac-dependent junction stabilization are not well under-
stood. Ajuba, a LIM domain protein, colocalizes with cad-
herins, yet Ajuba function at junctions is unknown. We 
show  that,  in  Ajuba-depleted  cells,  Rac  activation  and   
actin accumulation at cadherin receptors was impaired, 
and junctions did not sustain mechanical stress. The Rac 
effector PAK1 was also transiently activated upon cell–cell 
adhesion  and  directly  phosphorylated  Ajuba  (Thr172).   
Interestingly, similar to Ajuba depletion, blocking PAK1 
activation perturbed junction maintenance and actin re-
cruitment. Expression of phosphomimetic Ajuba rescued 
the effects of PAK1 inhibition. Ajuba bound directly to 
Rac·GDP  or  Rac·GTP,  but  phosphorylated  Ajuba  inter-
acted preferentially with active Rac. Rather than facilitat-
ing  Rac recruitment to junctions, Ajuba modulated Rac 
dynamics at contacts depending on its phosphorylation 
status.  Thus,  a  Rac–PAK1–Ajuba  feedback  loop  inte-
grates  spatiotemporal  signaling  with  actin  remodeling   
at  cell–cell  contacts  and  stabilizes  preassembled  cad-
herin complexes.
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Figure 1.  Ajuba regulates junction maintenance. Keratinocytes were transfected with control scramble oligos (scr, ctrl) or Ajuba RNAi oligos with 
or without expression of siRNA-resistant Ajuba (mAjuba). (A) Lysates were analyzed by Western blotting with the antibodies indicated on the left.   
(B and C) Keratinocytes were preextracted with 0.5% Triton X-100–containing buffer, fixed, and stained for E-cadherin. The amount of E-cadherin insoluble 
pool at junctions was quantified and expressed relative to control (arbitrarily set as 100). (D and E) Aggregation of RNAi-treated cells was tested in hanging-
drop suspension. Representative images are shown before (time 0), after addition of calcium ions for 2 h, and after moderate trituration (dissociation). 
Knock-down and expression of exogenous RNAi-resistant Ajuba were confirmed for each experiment. (E) Average size of all disaggregates after trituration 
was corrected for the size of each aggregate before trituration (2 h) and expressed relative to control samples (Scr., set as 100%). (F) siRNA-transfected 
cells were incubated with beads coated with BSA or anti–E-cadherin antibody. After washes, cells were fixed, stained for F-actin, and imaged. Arrows point 857 Ajuba regulates Rac activation by junctions • Nola et al.
The fact that the functions of Ajuba and Rac may be en-
twined in cell–cell junctions defines a potential wide-spread 
mechanism for the dynamic regulation of adhesive sites by 
Rac (cell–substratum and cell–cell adhesion). In this paper, 
we set out to test the hypothesis that Ajuba participates in Rac 
activation at junctions and contributes to cytoskeletal reorga-
nization necessary for cadherin adhesion. We find that Ajuba 
is not required for assembly, but rather for the maintenance   
of stable contacts. In the absence of Ajuba, Rac activation by 
cell–cell adhesion is perturbed and cadherin complexes are 
severely compromised in F-actin recruitment. We unravel the 
mechanisms underlying Ajuba function in Rac activation and 
identify a key role for the kinase PAK1, a known Rac effector, 
in this process.
Results
Ajuba is necessary for the maintenance of 
stable cell–cell adhesion
Human  keratinocytes  were  transfected  with  different  siRNA 
oligos  targeting Ajuba  (Fig.  1).  Depletion  of Ajuba  did  not   
affect the expression levels of junctional proteins such as   
E-cadherin, or - and -catenins (Fig. 1 A). No difference in   
E-cadherin levels at newly formed cell–cell contacts was ob-
served in the absence of Ajuba by standard immunostaining 
(unpublished  data).  When  keratinocytes  were  preextracted 
with detergent before fixation, an insoluble pool of E-cadherin 
was found in controls, as shown in our previous work (Braga   
et al., 1995a). Interestingly, a significant reduction on insolu-
ble E-cadherin levels is observed after Ajuba RNAi (Fig. 1,   
B and C).
To assess changes in cadherin adhesion quantitatively, we 
used aggregation assays (Thoreson et al., 2000; Ehrlich et al., 
2002) in which the size of aggregates correlates with the number 
and strength of cell–cell contacts (Takeichi, 1977). Formation of 
junctions as well as their maintenance can be evaluated in this 
assay (resistance to shear stress upon trituration; Ehrlich et al., 
2002). The size of aggregates before trituration (2 h) was not af-
fected by Ajuba RNAi, suggesting that Ajuba did not regulate 
assembly of junctions. Compared with control cells, RNAi de-
pletion of Ajuba approximately halved the size of aggregates   
after dissociation (Fig. 1, D and E). This effect was rescued sig-
nificantly by overexpression of Ajuba mouse homologue that is 
siRNA resistant (mAjuba; Fig. 1, D and E). Our results indicate 
that Ajuba contributes to stabilization of preformed junctions.
A  potential  mechanism  for  junction  stabilization  is  via   
F-actin recruitment to cadherin complexes. To determine whether 
Ajuba participates in this process, we used latex beads coated 
with an anti–E-cadherin antibody to cluster cadherins and trigger 
F-actin accumulation (Braga et al., 1997). -Catenin is recruited 
to cadherin beads but not talin (Braga et al., 1997), indicating the 
contacts or how it modulates epithelia-specific actin remodel-
ing is not completely understood.
Ajuba is an actin-binding protein of the family of LIM 
domain proteins containing Ajuba, LIMD1, WTIP, Zyxin, 
LPP, and Trip6 (Kadrmas and Beckerle, 2004). Members of 
this family are characterized by two or three C-terminal LIM 
domains and an N-terminal PreLIM region. Ajuba localizes at 
focal adhesions, nucleus, and preferentially at cell–cell con-
tacts in epithelial cells. Consistent with its localization at mul-
tiple sites, Ajuba is involved in several cellular processes such 
as cell fate determination (Kanungo et al., 2000; Nagai et al., 
2010), repression of gene transcription (Ayyanathan et al., 2007; 
Hou et al., 2008, 2010a; Langer et al., 2008; Montoya-Durango   
et al., 2008), mitotic commitment (Hirota et al., 2003), cell–
cell adhesion (Marie et al., 2003), and migration (Kisseleva   
et  al.,  2005;  Pratt  et  al.,  2005).  Underlying  these  distinct 
functions is the ability of Ajuba to interact with signaling and 
scaffolding  molecules  such  as  PIPKI  (Kisseleva  et  al., 
2005), Grb2 (Goyal et al., 1999), and 14-3-3 proteins (Hou   
et al., 2010b), and to modulate Wnt (Haraguchi et al., 2008)   
and Rac signaling (Pratt et al., 2005).
The regulation of Rac function by Ajuba is particularly 
interesting. In fibroblasts from Ajuba-null mice, wound healing 
is delayed due to reduced Rac activation at the leading edge, 
thereby interfering with forward movement (Pratt et al., 2005). 
Interestingly, Ajuba is not required for PDGF-dependent Rac 
activation, indicating the specificity of this process (Pratt et al., 
2005). Taken together, there is the intriguing possibility that 
Ajuba can modulate Rac function in focal adhesions by provid-
ing spatiotemporal clues. An important point to address is 
whether the regulation of Rac activation by Ajuba is relevant 
for cell–cell junctions and associated actin reorganization.
Ajuba-null mouse keratinocytes display abnormal cell–
cell junction formation and/or stability (Marie et al., 2003). Yet, 
the molecular mechanisms that underpin stabilization of junc-
tions by Ajuba are far from elucidated. We envisage two poten-
tial mechanisms: a potential cross talk with Rac function, similar 
to what is described for fibroblast migration (Pratt et al., 2005), 
or a direct participation of Ajuba on actin remodeling at cell–
cell contacts. These two mechanisms are not mutually exclusive 
and may cooperate with each other.
Although Ajuba is an actin-binding protein (Marie et al., 
2003), the specific actin activities regulated by Ajuba to re-
model the actin cytoskeleton are not currently known. Ajuba 
localizes at junctions via a direct interaction between its LIM 
domains and -catenin, while the PreLIM domain binds directly 
to F-actin (Marie et al., 2003). Thus, Ajuba could stabilize junc-
tions by remodeling F-actin at cell–cell contacts and/or by con-
necting cadherin complexes with the underlying cytoskeleton. 
An interesting point to test is whether Rac signaling modulates 
any of these two possibilities.
at beads without F-actin accumulation; arrowheads show actin recruitment (zoom). (G) Quantification of data shown in F. Beads containing F-actin were 
visually scored and expressed as percentage of total attached beads in each sample. Dashed line represents nonspecific binding observed with control 
BSA-coated beads. Between 40 and 200 beads were counted for each group per experiment. Data represent mean and SD of three independent experi-
ments (hereafter n = 3). Molecular weight markers are shown as kD (A and D). *, P < 0.03; **, P < 0.009; ***, P < 0.004. Bars: 10 µm or 200 µm.
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Ajuba interacts in vitro directly and 
specifically with Rac
The participation of Ajuba in F-actin recruitment and mainte-
nance of junctions is intriguing, considering that in keratino-
cytes Rac is necessary for these events (Braga et al., 1997). We 
investigated whether Rac and Ajuba can interact (Fig. 2).   
Interestingly, Ajuba bound to active Rac (Rac
Q61L), but not to 
active Rho (Rho
Q63L) or Cdc42 (Cdc42
Q61L; Fig. 2, A and B). 
Using  in  vitro–translated  LIM  domain–containing  proteins,   
active Rac bound selectively to Ajuba and Trip6, but not to 
specificity of this assay. Beads coated with BSA gave the non-
specific binding/recruitment levels (Fig. 1, F and G, dashed line). 
Ajuba depletion reduced significantly the proportion of anti- 
cadherin beads containing actin when compared with control   
oligos (Fig. 1 G). As cadherins are clustered by antibody-coated 
beads, we concluded that Ajuba participates in downstream events 
from cadherin receptors rather than clustering, by itself. Taken 
together, these data demonstrate that Ajuba regulation of F-actin 
recruitment to cadherin receptors (Fig. 1 G) may explain in part 
its stabilization of preformed cell–cell contacts (Fig. 1, B–E).
Figure 2.  Ajuba PreLIM interacts directly with 
Rac in vitro. GST-tagged small GTPases were 
incubated with (A and G) COS-7 lysates ex-
pressing full-length Ajuba, (C and E) in vitro 
translated Ajuba, or other LIM proteins. Immuno-
blot  of  myc-tagged  constructs  (IB:  anti-myc) 
and GST-proteins as Amido black staining are 
shown (A, C, E, and G). -Catenin was used 
as positive control (A and G). Quantification 
of  experiments  is  shown  as  binding  relative   
to  GST  (B  and  H)  or  to  Ajuba  full-length   
(D and F). (A and B) Activated forms of Rac (GST-
Rac
Q61L),  RhoA  (GST-RhoA
Q63L),  and  Cdc42 
(GST-Cdc42 [GST-Cdc42
Q61L]) were incubated 
with lysates expressing full-length Ajuba (myc-
Ajuba FL). (C and D) Specificity of Ajuba inter-
action with active Rac. Ajuba, LIMD1, or Trip6 
were  allowed  to  interact  with  GST  or  GST-
Rac
Q61L. (E and F) Full-length (FL) and Ajuba 
fragments PreLIM (Pre) or LIM were tested for 
binding to activated Rac. (G and H) Wild-type 
Rac  (GST-Rac
WT)  was  loaded  with  GTPS  or 
GDP  and  incubated  with  lysates  expressing 
myc-tagged full-length Ajuba. Histograms rep-
resent the mean and SD. n = 3. **, P < 0.009; 
***, P < 0.005; n.s., nonsignificant.859 Ajuba regulates Rac activation by junctions • Nola et al.
LIMD1 (Fig. 2, C and D; IVT). These results indicate selectiv-
ity of Rac interaction with some LIM proteins.
Consistent with the above data, we mapped the Ajuba 
PreLIM region as the site of interaction with active Rac (Fig. 2, 
E and F; Fig. S1), which is the most divergent region of LIM 
proteins. To investigate whether Ajuba interaction depends on 
Rac activation, we quantified its binding to wild-type Rac (WT) 
loaded with GDP or GTPS, a nonhydrolysable form (Fig. 2,   
G and H). No significant difference was observed in the inter-
action with Rac∙GDP or Rac∙GTPS. Altogether, these results 
demonstrate that (a) Ajuba and Trip6 bind to Rac, (b) Ajuba 
binds to Rac independently of its activation status, and (c) Ajuba 
PreLIM region mediates a direct interaction with Rac.
Ajuba is required for Rac activation 
induced by cell–cell contacts
The fact that Rac interacts directly with Ajuba PreLIM region 
(Fig. 2, E and F) raises the question of whether Ajuba colocal-
izes with Rac at junctions. In the absence of cell–cell contacts, 
cells displayed a mainly diffuse localization of endogenous Rac 
and endogenous Ajuba (Fig. 3 A, Ca
2+). Ajuba and Rac clearly 
colocalized at newly formed junctions (+Ca
2+). Time-lapse ex-
periments showed that both proteins were concomitantly en-
riched as soon as 4 min after junction formation (Fig. S2). The 
above results suggest that Ajuba may facilitate Rac recruitment 
to junctions. However, Ajuba siRNA did not significantly per-
turb GFP-Rac
WT relocalization to cell–cell contacts (Fig. 3,   
B and C). These data indicate that Ajuba colocalizes with Rac 
at junctions, but Ajuba is not required for Rac recruitment to 
newly formed cell–cell contacts.
Although Ajuba and Rac may be recruited to junctions in-
dependently, Ajuba RNAi could impair cadherin-induced Rac 
activation in keratinocytes or behave as a scaffolding protein 
for Rac at cell–cell contacts. We tested the first possibility using 
GST-PAK-CRIB pull-down and FRET assays (Fig. 3, D–I). 
Basal levels of Rac∙GTP in Ajuba-depleted cells were clearly 
decreased compared with control (Fig. 3 E). However, this   
effect is not related to junctions and could be an artifact due to 
disruption of the cytoskeleton (Nakamura et al., 2011). After 
junction assembly, Rac was activated in controls treated with 
scrambled oligos (Fig. 3 F). When expressed relative to basal 
levels (time-zero Ajuba RNAi) a significant difference in Rac 
activity in Ajuba-depleted cells was observed at 20 min, but not 
earlier (Fig. 3 F). We concluded that Ajuba is not essential for 
initial Rac activation by junctions, but contributes to its activa-
tion at later time points.
We reasoned that Ajuba may facilitate local Rac activa-
tion at junctions. To test this, cells were transfected with control   
or Ajuba siRNA oligos and the unimolecular FRET biosensor 
mRFP1-Raichu-Rac-GFP (Makrogianneli et al., 2009). Intra-
molecular FRET between GFP donor and mRFP1 acceptor   
occurs when Rac binds to GTP. This is detectable by a shorten-
ing of the donor GFP fluorescence lifetime () as measured by 
multi-photon FLIM (Fig. 3, G–I). After 20 min of junction   
assembly, Rac activation was particularly visible at cell–cell 
contacts by FRET in control keratinocytes (cell #1 and cell #2). 
We also observed a concomitant cytoplasmic Rac activation in 
about half of the cells analyzed (i.e., cell #2). We selectively 
measured FRET efficiency at junctions (100 junctions per 
sample; see Materials and methods) and observed a significant 
decrease of FRET efficiency in Ajuba-depleted cells (Fig. 3 I). 
Thus, biochemical and in situ analyses demonstrate that Ajuba 
is necessary for appropriate levels of Rac activation by junc-
tions. Importantly, this regulation is specific, as Ajuba is not   
required for Rac activation after EGF (Fig. 3 J) or PDGF 
stimulation (Pratt et al., 2005). However, KGF-dependent acti-
vation of Rac was reduced in the absence of Ajuba, indicating 
selectivity for growth factor signaling.
PAK1 inhibition phenocopies depletion  
of Ajuba
PAK1 is a serine-threonine kinase Rac effector that has differ-
ent cellular functions, including actin cytoskeleton rearrange-
ments (Bokoch, 2003). PAK1 localizes at junctions and has 
been  implicated  in  HGF-dependent  junction  destabilization 
(Zegers et al., 2003). PAK1 is the only member of the Group I 
PAKs (PAKs 1–3) expressed in cultured keratinocytes (Lozano 
et al., 2008). We show here that PAK1 is transiently activated 
by junction assembly in controls treated with the inactive 
compound PIR-3.5 (Fig. 4 A; Flaiz et al., 2009). Interestingly, 
this effect requires PAK1 auto-activation as it is prevented 
after treatment with IPA3, a specific inhibitor of Group I PAKs 
(Fig. 4 A; Deacon et al., 2008).
To address whether PAK1 is required for junction sta-
bilization,  aggregation  was  performed  using  cells  incubated 
with IPA3, PIR3.5, or transfected with PAK1 auto-inhibitory 
domain (PAK
AID; Fig. 4, B and C; Zhao et al., 1998). Interfering 
with PAK1 activity did not perturb formation of aggregates 
(Fig. 4 B; 2 h), consistent with our previous work on PAK   
depletion and junction assembly (Lozano et al., 2008). Instead, 
prevention of PAK activation increased aggregate size slightly 
(unpublished data). Interestingly, after trituration, we found that 
the sizes of the dissociated aggregates (diss.; normalized to 2 h 
initial aggregate size) were notably reduced upon PAK1 inhibi-
tion. The latter was significantly different when compared with 
controls treated with DMSO, PIR-3.5, or empty vector (Fig. 4 C). 
This result suggests an involvement of PAK1 in junction main-
tenance rather than assembly.
Furthermore,  inhibition  of  PAK1  using  IPA-3  signifi-
cantly decreased the proportion of anti-cadherin beads able to 
recruit F-actin compared with control (Fig. 4, D and E). Similar 
results were seen after expression of PAK-AID, but not a mu-
tant PAK-AID
L107F that does not interact with PAK kinase do-
main (Fig. 4, F and G; Arias-Romero et al., 2010). Both effects 
(reduced aggregate size upon dissociation and perturbed actin 
recruitment) were not as strong as observed after Ajuba RNAi 
(Fig. 1). We concluded that PAK1 inhibition partially pheno-
copies Ajuba depletion (Fig. 1) and Rac1 inhibition in keratino-
cytes (Braga et al., 1997).
PAK1 phosphorylates Ajuba
Previous studies indicate that Ajuba may be phosphorylated 
(Daub et al., 2008; Haraguchi et al., 2008; Oppermann et al., 
2009). However, no kinase or the functional consequences of JCB • VOLUME 195 • NUMBER 5 • 2011   860
Figure 3.  Ajuba is required for Rac activation at cell–cell contacts. Keratinocytes grown in the absence of contacts (Ca
2+) were induced to form junctions 
by addition of calcium for 20 min (+Ca
2+). Cells were stained, imaged, and localization of different constructs at junctions quantified. (A) Endogenous 
Ajuba and endogenous Rac relocalize upon junction assembly. Merged images and zoom of the boxed area are shown on the right. A line scan plot   
shows the fluorescence intensity of Rac and Ajuba at junctions. (B and C) Cells were treated with control (ctrl) or Ajuba RNAi oligo, transfected with   
GFP-Rac
WT, and stained for E-cadherin. Junctions containing GFP-Rac
WT were expressed as the percentage of total number of junctions in each sample. 
(D–I) Rac activity induced by cell–cell contact assembly was evaluated biochemically (D–F) or in situ (G–I). (D) Cells depleted of Ajuba were induced to assemble 
junctions for up to 20 min, and lysates used in pull-downs to determine Rac activation. Samples were probed with anti-Ajuba and anti-Rac antibodies to 
detect active Rac (Rac∙GTP) and total levels of Rac in lysates (Total Rac). GST-PAK-CRIB is shown by Amido Black staining. Quantification of basal (without 
calcium, E) and junction-induced Rac∙GTP levels (with calcium, F) are shown. Values are expressed relative to time-zero control in each group (scramble or 861 Ajuba regulates Rac activation by junctions • Nola et al.
the formation of thick actin bundles. The latter were less com-
pact and straight than bundles induced by -catenin (Rimm   
et al., 1995). Low speed actin sedimentation assays confirmed 
these results (Fig. 6 D), as addition of Ajuba PreLIM region   
to  preassembled  actin  filaments  enhanced  the  sedimentation   
of actin bundles and long filaments (pellet fraction, P; Fig. 6 D) 
compared with GST (Fig. 6 D). Ajuba LIM domains do not bind 
F-actin (Marie et al., 2003) and behaved as expected (i.e., no 
bundling activity; Fig. 6 D).
To address whether F-actin bundling is regulated by Ajuba 
phosphorylation, Ajuba mutants were tested. No major differ-
ence was detected between the ability of wild-type PreLIM 
(WT) or its phosphomimetic counterpart (TD) to bundle fila-
ments (Fig. 6 E). As controls, none of the proteins used precipi-
tated by themselves in the absence of F-actin (Fig. 6, D and E; 
bottom panels). Collectively, these complementary data reveal 
that the PreLIM region of Ajuba bundles actin filaments and that 
this function is not regulated by phosphorylation. The above re-
sults suggest that alternative mechanisms should be in place to 
explain the role of PAK>Ajuba in junction stabilization.
Phosphorylation of Ajuba enhances its 
binding to active Rac
In the context of epithelial junctions, we envisioned two other 
processes regulated by phosphorylation: Ajuba localization at 
cell–cell contacts or its interaction with Rac. To address the for-
mer, different RFP-Ajuba mutants were expressed and junctions 
induced for 20 min (Fig. 7, A–C). No difference in junctional 
distribution of full-length proteins was observed among Ajuba
WT 
(WT), Ajuba
T172A (TA), or Ajuba
T172D (TD, Fig. 7, A and B). 
Ajuba is able to dimerize (Fig. S3) and this could interfere with 
the distribution of exogenous proteins. However, similar local-
ization of mutants was obtained when transfected in Ajuba- 
depleted cells (Fig. 7 C). Thus, Ajuba phosphorylation at the 
PreLIM region does not regulate its localization at cell–cell con-
tacts. These results are in accordance with the requirement of the 
LIM domains for localization at junctions (Marie et al., 2003).
It is feasible that Ajuba interaction with Rac at junctions 
may be modulated by phosphorylation of the PreLIM region 
(Fig. 5), which also binds to Rac (Fig. 2, G and H). Using FRAP, 
we investigated Rac dynamics at newly formed junctions (Fig. 7, 
D–F). GFP-Rac
WT was used, as expression of active Rac can 
destabilize  cell–cell  adhesion  in  keratinocytes  (Braga  et  al., 
2000). The majority of Rac
WT is found GDP bound, as only a 
small proportion is activated upon a stimulus (1%; Ren et al., 
1999). Therefore, the readout of FRAP experiments reflects the 
dynamics of Rac∙GDP, as Rac∙GTP levels induced by junction 
assembly are not detected under these conditions. The bleaching 
efficiency was equivalent among samples and across different 
Ajuba phosphorylation was identified. Due to the similarities of 
Ajuba depletion and PAK1 inhibition on cell–cell adhesion, we 
addressed whether Ajuba is a substrate of PAK1. In vitro phos-
phorylation  assays  using  purified  proteins  showed  that  full-
length Ajuba can be readily phosphorylated by PAK1 (Fig. 5 A). 
Phosphorylation occurs at the PreLIM region in a time- and 
concentration-dependent manner (Fig. 5, B–D). Quantification 
of the relative levels of 
32P incorporation demonstrated that 
Ajuba  phosphorylation  is  readily  saturated  at  30  pmol  after   
5 min incubation (Fig. 5 D; Fig. S4, D–F). Relative levels of 
[
32P]Ajuba were comparable to PAK1 auto-phosphorylation or 
[
32P]MBP  (positive  control;  Fig.  S4,  D–F),  suggesting  that 
Ajuba is efficiently phosphorylated by PAK1.
PAK1 is a promiscuous kinase that phosphorylates serine 
and threonine residues, but consensus sequences and preferred 
flanking residues are known (Fig. S4 A; Miller et al., 2008).   
In vitro phosphorylation of the PreLIM region followed by mass 
spectrometry identified a single phosphopeptide with three puta-
tive PAK1 phosphorylation site(s) (Fig. 5 E). Mutations of these 
different amino acids to alanine showed that PAK1 phosphory-
lates Ajuba at a single site, threonine 172 of mouse Ajuba 
(human residue 161; Fig. 5 F). This motif is not picked up by 
online searches for kinase substrates, as it does not fit precisely the 
consensus motif RRxS/T (conserved arginine at position 1   
in Ajuba protein rather than 2; Miller et al., 2008).
Ajuba bundles actin filaments independently 
of its phosphorylation status
As the PreLIM region interacts with F-actin and Ajuba deple-
tion reduces F-actin recruitment to cadherins (Fig. 1 G), we 
envisaged that phosphorylation at T172 may modulate actin   
reorganization  downstream  of  PAK1.  We  tested  whether 
PAK1 inhibition of F-actin recruitment to cadherins is rescued 
by a phosphomimetic mutant of Ajuba (Ajuba
T172D). Blocking 
PAK1 activation by IPA-3 reduced the percentage of cadherin 
beads containing F-actin on cells expressing wild-type Ajuba 
(Fig. 6, A and B), similar to what was observed for endoge-
nous Ajuba (Fig. 4 D). Expression of a nonphosphorylatable 
Ajuba (Ajuba
T172A, TA) exhibited a comparable effect. Inter-
estingly, expression of Ajuba
T172D (TD) significantly rescued 
PAK1 inhibition and reversed the decrease in the number of 
beads labeled with F-actin (Fig. 6 B). Although PAK1 inhibi-
tion did not prevent actin recruitment completely, these data 
indicate that phosphorylation of threonine 172 on Ajuba con-
tributes to the regulation of actin remodeling triggered by cad-
herin clustering.
It  is  unclear  which  actin  reorganization  process  Ajuba 
regulates to stabilize junctions. Using electron microscopy 
(Fig. 6 C), we observed that Ajuba PreLIM region induced 
Ajuba siRNA). (G) Cells depleted of Ajuba were transfected with the unimolecular biosensor mRFP1-Raichu-Rac-GFP. Multi-photon FLIM was used to image 
intramolecular FRET between GFP and mRFP1 upon Rac activation. Pseudocolored images show shortening of GFP fluorescence lifetime (, expressed in   
ns) as Rac activation. Two representative distributions of active Rac are shown for controls (cell #1 and #2). Arrows show Rac activation at junctions.   
(H) Representative blots showing Ajuba depletion. (I) FRET efficiency was measured at junctions (see Materials and methods) and shown as box plots 
(25th and 75th percentiles, medians as horizontal lines, and minimal/maximal values as vertical bars). About 100 contacts per condition across independent 
experiments were quantified. (J) Keratinocytes were stimulated with EGF or KGF and Rac activation assessed as described for D above. Graphs show the 
mean and standard error. n > 3. *, P < 0.04; **; P < 0.02; ***, P < 0.001. n.s., nonsignificant. Bars, 10 µm.
 JCB • VOLUME 195 • NUMBER 5 • 2011   862
Figure 4.  PAK contributes to junction stabilization and F-actin recruitment. (A–E) PAK activity was inhibited in keratinocytes by treatment with IPA-3; treat-
ment with DMSO or the inactive compound PIR-3.5 was used as control. (B, C, F, and G) Alternatively, endogenous PAK1 was blocked by expression of 
the auto-inhibitory domain (PAK
AID). As controls, empty vector or PAK
AID mutated to abolish interaction with PAK1 was used (L107F). (A) Cells were induced 
to form new junctions, endogenous PAK was immunoprecipitated and subjected to in vitro kinase assay using MBP as substrate and [
32P]ATP (+/). Levels 
of PAK1 are shown by Western blot and MBP by Coomassie blue. (B) Cells were allowed to aggregate for 2 h and mildly dissociated by pipetting (diss.). 
(C) Relative size of remaining aggregates was calculated and expressed as percentage of their control as described in Fig. 1. (D–G) F-actin recruitment to 
beads coated with E-cadherin antibody was tested. Arrow points at attached beads without F-actin; arrowheads show F-actin recruitment. (E and G) The 
percentage of attached beads containing F-actin was quantified as described in Fig. 1. Dashed line represents baseline of control BSA-coated beads. n = 3. 
*, P < 0.003; **, P < 0.009; ***, P < 0.0002. n.s., nonsignificant. Bars: (B) 200 µm, (D and F) 10 µm.863 Ajuba regulates Rac activation by junctions • Nola et al.
phosphorylated Ajuba PreLIM was able to pull down 50% more 
activated Rac than controls (Fig. S4, B and C). These results 
were confirmed by a preferential interaction of Ajuba
T172A to 
Rac
WT, as a read-out for Rac∙GDP (Fig. 7, G and H). Conversely, 
Ajuba
T172D (TD) was able to pull down twofold more active Rac 
than Ajuba
T172A or Ajuba
WT (WT, Rac
Q61L; Fig. 7, G and H).
In vivo, we predict that new junction assembly activates 
Rac  (Fig.  3),  triggers  PAK  auto-activation  (Fig.  4),  and  in-
creases Rac binding to Ajuba in a PAK-dependent manner. To 
test this prediction, junctions were induced in the presence of 
experiments (60–70%, Fig. 7 E). When coexpressed with Ajuba
WT 
or phosphomimetic Ajuba
T172D (TD), Rac
WT had a fast recovery 
time (Fig. 7 F). However, expression of Ajuba
T172A (TA) led to a 
significant increase in the half-life of Rac
WT at junctions. These 
data indicate that replacement of the pool of Rac∙GDP at junc-
tions is slower in the presence of Ajuba
T172A (Fig. 7 F).
These  results  could  be  explained  if  phosphorylation  at 
T172 (or lack of) affects the ability of Ajuba to interact with Rac 
and thus interfere with the release or retention of Rac at cell–cell 
contacts. Using purified proteins and in vitro phosphorylation, 
Figure 5.  PAK phosphorylates Ajuba. (A–C) Purified full-length Ajuba (FL) and the truncation mutants PreLIM (Pre) or LIM (LIM) were incubated in vitro 
with PAK1 kinase domain with or without radioactive ATP (
32P-ATP). Phosphorylated bands are shown by autoradiography and fusion proteins by 
Coomassie blue staining. (A) Full-length Ajuba is phosphorylated by PAK1; MBP was used as positive control; PAK1 auto-phosphorylates itself. (B) Time 
course of Ajuba phosphorylation. (C) Mapping of Ajuba-phosphorylated region. (D) Different concentrations of Ajuba PreLIM (7.5, 15, 30, 60, and 
120 pmol), GST, or MBP were incubated with PAK kinase domain (80 pmol) in an in vitro kinase assay for 5 min. (E) Phosphopeptide isolated after 
Ajuba phosphorylation by PAK1 using mass spectrometry. Three putative phosphorylation sites are shown (asterisks). (F) PAK1 phosphorylates Ajuba at 
residue 172. Different alanine mutations were prepared in Ajuba PreLIM region (T172A, S172A, or S176A) and GST fusion proteins phosphorylated 
in vitro by PAK1.JCB • VOLUME 195 • NUMBER 5 • 2011   864
Figure 6.  Ajuba bundles F-actin independently of phosphorylation. (A) Cells expressing RFP-tagged Ajuba (WT), Ajuba T172A (TA), or T172D (TD) were 
treated with DMSO or IPA-3 to inhibit PAK1 for 10 min. F-actin recruitment to anti-cadherin–coated beads was detected by phalloidin staining. Arrowheads 
show actin-recruited beads; arrows point beads with no F-actin accumulation. (B) Quantification of the percentage of attached beads containing F-actin and 
attached to expressing cells. Dashed line shows baseline (control BSA-coated beads). (C) Negative staining electron micrographs of actin filaments alone 
(, 5 µM) or mixed with -catenin as positive control (+ -cat, 1.8 µM) or Ajuba PreLIM (+ PreLIM, 2 µM). (D and E) Low speed cosedimentation assays.   
Indicated GST fusion proteins were incubated with polymerized actin in vitro, centrifuged to separate bundles (pellet, P) from short filaments (supernatant, S),   
resolved on SDS-PAGE, and stained with Coomassie blue. Actin () and GST alone were used as negative controls, -catenin as positive control. As ad-
ditional control, fusion proteins were processed as above but without actin (Actin; arrowheads on bottom panels). n = 3. *, P < 0.025; **, P < 0.01. 
n.s., nonsignificant. Bars: (A) 20 µm; (C) 100 nm.865 Ajuba regulates Rac activation by junctions • Nola et al.
Figure 7.  PAK phosphorylation increases binding of Ajuba to active Rac. (A) Keratinocytes transfected with full-length RFP-Ajuba (wild-type, WT), non-
phosphorylatable (T172A, TA), or phosphomimetic (T172D, TD) mutants were induced to form junctions, fixed, and stained for E-cadherin. Arrows point at 
Ajuba at junctions (boxed magnifications). (B and C) Quantification of exogenous Ajuba localization in normal (B) and Ajuba-depleted keratinocytes (C). 
Values are expressed as percentage of junctions containing Ajuba WT. (D–F) Keratinocytes expressing GFP-Rac
WT and RFP-Ajuba (WT, TA, or TD) were 
induced to form junctions for 15–20 min (left) and subjected to fluorescence recovery after photobleaching (FRAP). (D) Pseudocolored fluorescence intensity 
of GFP-Rac at cell–cell contact before and after bleaching is shown on right panels. Dotted boxes indicate bleached region. (E) Quantification of GFP-Rac
WT 
bleaching efficiency at time zero (average of at least 11 cells per sample). (F) Quantification of GFP-Rac after bleaching expressed according to half-time 
of fluorescence recovery. The numbers of junctions quantified were: RFP-Ajuba WT (15), TA (12), TD (18). (G and H) GST pull-down was performed using 
immobilized GST, GST-PreLIM WT, TD, or TA mutants and Rac
WT or active Rac (Rac
Q61L). Bound Rac and GST fusion proteins were detected by immunoblot-
ting (IB) and Amido Black staining, respectively. (H) Relative Rac binding with indicated proteins was quantified and normalized to levels of GST-PreLIM 
WT. (I and J) Cells were pretreated with IPA-3 to inhibit PAK1 or PIR-3.5 as control. After junction assembly, the ability of endogenous Ajuba to bind to 
GST-Rac
WT or GST was evaluated with pull-downs. Precipitated proteins and lysates were probed with anti-Ajuba antibodies. (J) Quantification of the above 
experiments. Error bars represent SEM (n = 3). *, P < 0.03; **, P < 0.02; ***, P < 0.003. n.s., nonsignificant. Bars, 20 µm.JCB • VOLUME 195 • NUMBER 5 • 2011   866
pools of insoluble E-cadherin and the strong inhibition of actin 
recruitment suggest that cell–cell contact stabilization by Ajuba 
may be explained by actin remodeling. Yet, our data indicate 
that this is not the full explanation. Three lines of evidence sug-
gest that Ajuba and Rac signaling are entwined. First, inhibiting 
PAK1 activation leads to smaller aggregates and reduced actin 
recruitment to clustered cadherins, similar to Ajuba depletion 
(this paper) or Rac inhibition (Braga et al., 1997; Ehrlich et al., 
2002; Lambert et al., 2002).
PAK1 is a serine-threonine kinase that regulates a vari-
ety of different processes (Bokoch, 2003). PAK1 localizes at 
junctions in epithelial cells (Zegers et al., 2003) and has an 
emerging role in tumor progression, epithelial morphogenesis, 
and cell–cell contact inhibition of motility (Bokoch, 2003; 
Zegers et al., 2003). Interestingly, PAK1 is transiently acti-
vated by junction assembly and specifically phosphorylates 
Ajuba (Fig. 8 A). PAK1 is known to phosphorylate other pro-
teins (Bokoch, 2003) that have been shown to stabilize cell–
cell contacts (Ivanov et al., 2007; Smutny et al., 2010). Yet, 
expression of Ajuba phosphomimetic mutant (Ajuba
T172D) res-
cues  actin  recruitment  to  cadherins  after  PAK1  inhibition. 
Thus, Ajuba appears to be the main PAK1 substrate that regu-
lates actin remodeling at cadherins.
Second, Rac requires Ajuba to maintain its activation at 
junctions. The fact that the initial Rac activation (5 min) is not 
disrupted is consistent with (a) the role of Ajuba in junction 
maintenance rather than assembly and (b) a prediction that Rac 
may be activated by multiple mechanisms upon junction assem-
bly (Braga and Yap, 2005). Interestingly, the interplay between 
Ajuba and Rac is specific for cell–cell contact formation: Ajuba 
depletion does not impair Rac activation after stimulation with 
EGF (this work) or PDGF (Pratt et al., 2005).
Third, Ajuba binds to Rac, but not RhoA or Cdc42. Simi-
lar to the interaction of Rac with PRK2 and PIP-5K (Vincent 
and Settleman, 1997; Tolias et al., 2000), Ajuba binds to both 
Rac∙GDP and Rac∙GTP (Fig. 8 A), indicating that Ajuba is not 
a  Rac  effector.  The  fact  that  Ajuba  modulates  Rac  activity   
in vivo suggests a unique role of Ajuba in integrating spatio-
temporal Rac signaling with cytoskeletal remodeling at junctions.
We envisage three mechanisms for how Ajuba regulates 
junction-induced Rac activation: Ajuba may facilitate Rac re-
cruitment to cell–cell contacts, recruit an exchange factor to 
activate Rac locally, or prevent Rac inactivation at junctions 
(Vigil et al., 2010). However, Rac localizes at junctions inde-
pendently of Ajuba and thus Ajuba regulates the activity levels 
of a Rac pool already found at sites of adhesion (Fig. 8 B).   
At present, we cannot formally exclude that Ajuba may recruit 
a Rac exchange factor to cell–cell contacts. Instead, our data 
suggest that Ajuba maintains active Rac at junctions, either as 
a scaffold protein or by preventing Rac inactivation by a GAP 
protein (i.e., via steric hindrance).
We hypothesize that cadherin-dependent Rac signaling 
triggers PAK1 activation and Ajuba phosphorylation, leading   
to a dynamic regulation of active Rac at junctions (Fig. 8 B). 
Our data strongly support our hypothesis: Ajuba localization at 
cell–cell contacts occurs independently of its phosphorylation 
status and phosphorylated Ajuba interacts preferentially with 
IPA3 or PIR3.5 and pull-downs were performed using GST-
Rac
WT that mimics inactive Rac (Fig. 7, I and J). Rac
WT was 
used to be consistent with FRAP experiments and avoid compe-
tition with effectors for binding to active Rac. Endogenous 
Ajuba interacted with Rac
WT at steady state (Fig. 7, I and J; time 
zero) because of its ability to bind to Rac∙GDP. When junctions 
are induced for 15 min, Ajuba binding levels are reduced, con-
sistent with the transient peak of PAK activation (Fig. 4 A) and 
decreased affinity of phosphorylated Ajuba to Rac∙GDP (Fig. 7, 
G and H). Conversely, Ajuba-Rac
WT interaction is increased   
after 60 min, which correlates with PAK1 inactivation (Fig. 4 A). 
These effects are abrogated when PAK1 is inhibited by IPA3. 
Taken together, these results reveal that, rather than perturbing 
Ajuba localization at junctions, phosphorylation by PAK1 in-
creases the affinity of endogenous Ajuba for active Rac.
Discussion
Rac activation at cadherin adhesive sites induces membrane   
expansion during contact assembly, actin recruitment, or traf-
ficking of cadherins to and from junctions (Nelson, 2008; Delva 
and Kowalczyk, 2009). We show that Ajuba fine-tunes Rac ac-
tivation at junctions, thereby contributing to cell–cell adhesion 
maintenance. In addition, PAK1, a serine-threonine kinase Rac 
effector (Bokoch, 2003), phosphorylates Ajuba. We unravel a 
novel PAK1>Ajuba cross talk that modulates actin reorganiza-
tion and Rac dynamics, leading to junction stabilization.
Ajuba depletion does not prevent junction assembly, but 
rather the maintenance of preassembled cell–cell contacts. Our 
data point to differences in the molecular regulation of forma-
tion versus stabilization of junctions, which is poorly under-
stood (Braga et al., 1999). Clearly, Ajuba has an auxiliary role 
as revealed when junctions are stressed, i.e., upon trituration. 
Yet, Ajuba may be important to other physiological events in 
which junctions are challenged by mechanical stress such as 
cytokinesis. Other LIM proteins (LPP and Zyxin) also localize 
at cell–cell and focal adhesions (Reinhard et al., 1995; Drees   
et al., 1999). However, they bind indirectly to F-actin and ap-
pear to reduce contacts by perturbing VASP function (Hansen 
and Beckerle, 2006).
The  mechanisms  underlying  F-actin  reorganization  at 
cadherin complexes are largely unexplored. Recent evidence 
suggests that actin polymerization cannot be the sole contribu-
tor to the F-actin pool at junctions. Theoretically, additional 
mechanisms could involve binding/bundling of preassembled 
filaments and/or cross-linking with underlying cortical cyto-
skeleton. That additional actin remodeling events occur is sup-
ported by Mège et al. (2006): (a) regulators of capping and 
linear  filaments  stabilize  cadherin  adhesion,  (b)  actin  cross-
linking and bundling proteins are found at junctions, and (c) 
-catenin inhibits actin polymerization (Drees et al., 2005). We 
show that Ajuba is able to bundle F-actin, which could accumu-
late linear actin filaments at cadherins.
Ajuba may contribute to the interaction of cadherin com-
plexes  with  the  cortical  cytoskeleton:  it  binds  directly  to   
-catenin via the LIM domains and F-actin via the PreLIM region 
(Fig. 8 A; Marie et al., 2003). After Ajuba RNAi, the reduced 867 Ajuba regulates Rac activation by junctions • Nola et al.
Our  data  are  consistent  with  a  wide-spread  interplay   
between signaling and cytoskeletal proteins to ensure spatio-
temporal coordination of Rac function in the stabilization of 
junctions. As similar regulation occurs during wound healing 
(Pratt et al., 2005), our results highlight the broad implications 
of Ajuba function for Rac signaling at adhesive events. It will 
be interesting to address whether Ajuba and PAK1 can also 
cooperate  in  cellular  processes  at  other  sites  where  both   
proteins localize (Kanungo et al., 2000; Hirota et al., 2003; 
Hou et al., 2010a).
Aberrant expression of PAK1 and Rac are critical events 
during  tumor  invasion  (Lozano  et  al.,  2003;  Kumar  et  al., 
2006). Although a putative role of Ajuba during tumorigenesis 
has not been investigated, Ajuba regulates proliferation and 
cell  fate  specification  (Kanungo  et  al.,  2000;  Ayyanathan   
et al., 2007), similar to its binding partners Rac and -catenin 
(Vasioukhin et al., 2001). We argue that Ajuba helps to main-
tain an epithelial phenotype due to its role on F-actin bundling 
and channeling Rac function to junctions. Furthermore, Ajuba 
may be an important component in the cross talk between 
cell–cell adhesion (this paper) and migration (Pratt et al., 
2005). When junctions are disrupted during tumor progres-
sion,  we  speculate  that  de-regulated  Ajuba  localization   
may  influence  the  level  and  specificity  of  Rac  signaling   
Rac∙GTP. The outcome of the change in affinity is the local 
regulation of Rac activity at junctions. In vivo, expression of 
Ajuba
T172A stabilizes inactive Rac at cell–cell contacts, which 
results in slower recovery fluorescence time of Rac∙GDP in 
FRAP experiments. In support of our findings, junction assem-
bly transiently reduces binding of endogenous Ajuba to Rac
WT, 
a process that requires PAK1 activity and correlates with the 
profile of PAK1 activation by junctions.
Serine-threonine  phosphorylation  of  small  GTPases   
(Ozdamar et al., 2005; Riento et al., 2005; Rolli-Derkinderen   
et al., 2010) or their upstream regulators (DerMardirossian et al., 
2004; Vigil et al., 2010) is a well-established mechanism to mod-
ulate GTPase function. Although other cytoskeletal proteins such 
as ERM have been shown to regulate GTPase activity, the latter 
occurs indirectly via modulation of Rho regulators (Fehon et al., 
2010). In contrast, Ajuba interacts directly with Rac and phos-
phorylated Ajuba helps to maintain transient levels of active Rac 
at junctions. This mechanism resembles the change in specificity 
of RhoGDI by phosphorylation, resulting in lower affinity for 
Rac (DerMardirossian et al., 2004). Junction assembly and re-
localization of Ajuba could provide a feedback loop and quick 
switch for retention of Rac∙GTP or Rac∙GDP at adhesive sites, 
depending on Ajuba phosphorylation (Fig. 8 B). Therefore, fine-
tuning of Rac activation after junction assembly is achieved.
Figure  8.  Summary  diagrams.  (A)  Ajuba  domain  or-
ganization: PreLIM region, three LIM domains, nuclear 
export  signal  (NES),  and  PAK1  phosphorylation  site. 
Protein partners are shown underneath each region.   
(B) Summary of the data presented. Upon cell–cell contact 
assembly, Ajuba and Rac are recruited independently to 
junctions (1). Ajuba interacts with both active (Rac∙GTP) 
and inactive Rac (Rac∙GDP) (2). Upon Rac activation by 
junctions,  PAK1  is  activated  by  auto-phosphorylation 
(3 and 4). Active PAK phosphorylates Ajuba, which in-
creases its affinity to active Rac. Thus, active Rac is sta-
bilized at cell–cell adhesion sites depending on Ajuba 
phosphorylation  levels,  thereby  fine-tuning  locally  Rac 
activation and dynamics (5). The outcome is sustained   
remodeling of actin filaments and junction stabilization 
(6). In the absence of Ajuba, Rac can still be recruited 
and activated by junction assembly, but this is not suf-
ficient to ensure resistance to mechanical stress.JCB • VOLUME 195 • NUMBER 5 • 2011   868
Rabbit polyclonal antiserum used were anti–-catenin (VB1), anti–-catenin 
(VB2; Braga et al., 1995a), anti-PAK1 (sc-882; Santa Cruz Biotechnology, 
Inc.), and affinity-purified anti-Ajuba (4897; Cell Signaling Technology 
and 9104). Alexa Fluor 488–Phalloidin (Invitrogen) and Fluorophore-
conjugated  antibodies  (Jackson  ImmunoResearch  Laboratories,  Inc.) 
and horseradish peroxidase–coupled antibodies (Dako) were purchased.
Immunofluorescence was performed essentially as described previ-
ously (Braga et al., 1997). In brief, cells were fixed in 3% paraformalde-
hyde for 10 min at RT and permeabilized with 0.1% Triton X-100 in 10% 
FCS/PBS for 10 min before sequential incubations with the primary and 
secondary  antibodies.  In  some  experiments,  cells  were  simultaneously 
fixed and permeabilized in 3% paraformaldehyde with 0.5% Triton X-100 
to reduce cytoplasmic signal. Coverslips were mounted in Mowiol. For en-
dogenous Rac staining, cells were fixed in 10% trichloroacetic acid/PBS, 
washed in 30 mM glycine in PBS and blocked with 3% BSA/0.1% Triton 
X-100 in PBS for 1 h.
Microscopy
Cells were imaged using an inverted microscope (Axiovert; Carl Zeiss) 
with a EC Plan-Neofluor 10x/0.3 NA phase-contrast objective (aggrega-
tion  assays;  Carl  Zeiss)  or  an  upright  fluorescence  microscope  (Provis 
AX70; Olympus) coupled to a monochrome camera (SPOT RT; SPOT Imag-
ing Solutions), using an oil immersion PlanApo 60x/1.40 NA objective 
(Olympus), and controlled by SimplePCI software (Hamamatsu Photonics). 
Live cell imaging and fluorescence recovery after photobleaching (FRAP) 
experiments were performed on a confocal laser scanning microscope 
(LSM 510; Carl Zeiss) equipped with a 37°C incubation chamber and 
using an oil-immersion PlanApochromat 63x/1.40 NA differential interfer-
ence contrast or an oil-immersion PlanApochromat 100x/1.40 NA Ph3 
objective. For FRAP, bleaching was performed using 10 iterations of 75% 
laser power and recovery was monitored every 783 ms for 38 s.
Fluorescent lifetime measurements were performed via time-correlated 
single-photon counting using a multiphoton microscope system comprising 
an upright microscope (TCS SP5; Leica) with a krypton-argon laser (Leica), 
a Mai Tai tunable infrared laser (set at 890 nm, 80 MHz; Newport Spec-
trophysics), and a single photon counter from Becker & Hickl GmbH. An 
oil-immersion PlanApochromat HCX 63x/1.40-0.6 NA objective (Leica) 
was used throughout. Acquisition was performed using LAS AF (Leica) and 
SPCM (Becker & Hickl GmbH) software. Pictures were processed using 
Adobe Photoshop or ImageJ (http://rsb.info.nih.gov/ij).
Protein purification and protein–protein interaction assays
In vitro translation of different proteins was performed using the Super-
Script II kit from Invitrogen. Fusion proteins were induced and purified   
using standard techniques. For insoluble GST-Ajuba full-length, the pellet 
was sequentially washed in 10 mM Tris-HCl, pH 8, 1 mM EDTA, 2% Triton   
X-100, 10 mM DTT, and distilled water containing 10 mM DTT. Extraction 
was performed by incubating the pellet in 8 M urea with 10 mM DTT with 
agitation at 30°C for 1 h. After centrifugation (25,000 g, 20 min, 4°C), 
supernatant  was  dialyzed  using  buffers  containing  20  mM  Tris-HCl,   
pH 7.5, 200 mM KCl, and gradual dilutions of urea (from 4 M to 0.2 mM) 
and DTT (from 10 mM to 0.5 mM) for refolding. Depending on the experi-
ment, fusion proteins were cleaved using Thrombin (Sigma-Aldrich) or Pre-
cission enzyme as required and then dialyzed (20 mM Tris-HCl, pH 7.5, 
and 0.5 mM DTT).
For pull-down assays, fusion proteins immobilized in GSH-Sepharose 
were incubated with in vitro–translated products or cleaved proteins. 
Supernatants were incubated in a buffer containing 10 mM Tris-HCl,   
pH 7.5, 200 mM NaCl, and 1 mM DTT, with GST or the different GST fusion 
proteins bound to the GSH-Sepharose beads, for 30 min at 4°C with rota-
tion. Beads were then washed four times with the same buffer and bound 
proteins detected by enhanced chemiluminescence (ECL; GE Healthcare). 
For interaction of endogenous Ajuba with wild-type Rac, keratinocytes 
were lysed (10 mM Tris-HCl, pH 7.5, 1% NP-40, 150 mM NaCl, 1 mM 
MgCl2, 50 mM NaF, 1 mM DTT, 5 µM Leupeptin, and 1 mM PMSF) and 
centrifuged at 8,800 g for 10 min at 4°C. Supernatant was incubated 
with 20 µg GST-Rac
WT for 1h. Precipitates were washed with lysis buffer 
three times.
Rac activation assays
GDP/GTP loading of Rac on glutathione–Sepharose beads was performed 
as reported previously (Self and Hall, 1995). Rac·GTP levels were as-
sessed in vivo by pull-down assays with GST-PAK-CRIB fusion protein as 
described previously (Sander et al., 1998; Betson et al., 2002). Junctions 
were induced for different periods of time by addition of calcium ions to 
avoid stimulation of GTPases with fresh serum, and lysates incubated with 
pathways and contribute to epithelial-to-mesenchymal tran-
sition (Ayyanathan et al., 2007; Hou et al., 2008; Langer et al., 
2008). Thus, our results have considerable implications to the 
regulation of epithelial homeostasis and tumorigenesis at the 
molecular, cellular, and tissue levels.
Materials and methods
Cell treatment, RNAi, and transfections
Normal human keratinocytes from neonatal foreskin (strain SF, passages 
3–6) were routinely grown on a mitomycin C–treated monolayer of 3T3   
fibroblasts at 37°C and 5% CO2 in standard medium (containing 1.8 mM 
CaCl2; Rheinwald and Green, 1975). Cells were switched to low calcium 
medium (0.1 mM CaCl2) when small colonies were visible and grown until 
confluent (Hodivala and Watt, 1994). For induction of cell–cell contacts, 
1.8 mM CaCl2 was added for different periods of times. For Triton X-100 
insolubility  of  cadherin  receptors,  cells  were  preextracted  with  a  CSK   
buffer (10 mM Pipes, pH 6.8, 50 mM NaCl, 3 mM MgCl2, 300 mM   
sucrose, and 0.5% Triton X-100) for 10 min at room temperature before 
fixation as described previously (Braga et al., 1995b).
Keratinocytes were preincubated with 20 µM IPA-3 (I2285; Sigma-
Aldrich) to inhibit PAK activity, as controls the inactive PIR-3.5 compound 
(TCS9528; TCris) or an equivalent volume of DMSO for 10 min. Human 
keratinocytes were transfected with cDNA or siRNA oligos with TransIT- 
keratinocyte (MirusBio; Cambridge Biosciences) or RNAiFect (QIAGEN), 
respectively. Following manufacturer’s instructions, redesigned siRNA oli-
gos were bought from Thermo Fisher Scientific (Ajuba D-021473-01 and 
D-021473-04 or control scrambled D-001206-13). Depletion of proteins 
was monitored for each experiment and in case depletion was less than 
70%, experiments were excluded.
Aggregation assays were performed as described previously (Thore-
son et al., 2000) with minor modifications. In brief, confluent keratinocytes 
in low calcium medium were detached from culture dishes using 0.1% tryp-
sin in Versene with 1 mM CaCl2 to prevent E-cadherin degradation. Cells 
in suspension (5 × 10
4/ml) were incubated for 2 h in standard calcium me-
dium as 20-µl hanging drops. Cells were dissociated by pipetting 10 times 
through a 200-µl tip.
COS-7 cells were grown in DME medium (Sigma-Aldrich) supple-
mented with 10% fetal calf serum (Serum Laboratories Ltd). COS-7 cells 
were transfected by Lipofectamine (Invitrogen) according to the manufac-
turer’s recommendations. Transfected COS-7 cells were lysed in lysis buffer 
(10 mM Tris-HCl, pH 7.5, 1% NP-40, 150 mM NaCl, 1 mM MgCl2,   
50 mM NaF, 1 mM DTT, 5 µM leupeptin, and 1 mM PMSF) and centri-
fuged at 8,800 g for 10 min at 4°C. Pellet was discarded and supernatant 
used in different assays.
Constructs, cloning, and mutagenesis
Auto-inhibitory domain of PAK (PAK
AID) in pRK5myc, PAK kinase domain 
in pGEX-2T (GST-PAK
KD), and the activated mutants Rac
Q61L, Cdc42
Q61L, 
and Rho
Q63L (pRK5myc and/or pGEX-2T vectors) were gifts from A. Hall 
(Sloan Kettering Institute, New York, NY). pEGFC1 containing the PAK1 
auto-inhibitory domain (PAK
AID, amino acids 83–149) or mutated to pre-
vent binding to endogenous PAK1 (PAK
AID L107F; Arias-Romero et al., 
2010) were provided by J. Chernoff (Fox Chase Center, Philadelphia, 
PA). pGEX2T-PAK-CRIB was a gift from J. Collard (Netherlands Cancer 
Institute,  Amsterdam,  The  Netherlands).  Myc-tagged  Ajuba  full-length 
(Kanungo et al., 2000), pGEX-2T-full-length Ajuba or truncation mutants 
containing PreLIM or LIM regions (Goyal et al., 1999), and mRFP1-full-
length Ajuba (RFP-Ajuba; Pratt et al., 2005) were used. GST–-catenin 
was provided by D. Rimm (Yale University, New Haven, CT). pEGFP-
Rac1 wild-type was provided by M. Cebecauer (Imperial College Lon-
don, London, UK). mRFP1-Raichu-Rac-GFP FRET plasmid containing Rac1 
CAAX box (Makrogianneli et al., 2009) was provided by T. Ng (King’s 
College London, London, UK).
Site-directed mutagenesis was performed using the QuikChange II 
kit (Agilent Technologies) according to the manufacturer’s recommenda-
tions to obtain the mutations T172D or T172A in RFP-Ajuba (full length) or 
GST-PreLIM mutants T172A, T172D, S173A, and S176A. Mutations were 
confirmed by sequencing.
Antibodies and immunostaining
The following primary mouse monoclonal antibodies were used against:   
E-cadherin (HECD-1; Cancer Research UK, London), Myc (9E10; Cancer 
Research UK), actin (C4; MP Biomedicals), and Rac (23A8; Millipore). 869 Ajuba regulates Rac activation by junctions • Nola et al.
GST-PAK-CRIB to fish out Rac activated by cell–cell contacts. To study the 
localization of active Rac in situ, keratinocytes expressing the biosensor 
mRFP1-Raichu-Rac-GFP (Makrogianneli et al., 2009) were induced to form 
junctions for 20 min (CaCl2 addition), fixed in 3% paraformaldehyde, and 
imaged. Fluorescent resonance energy transfer (FRET) was determined by 
fluorescence lifetime imaging microscopy (FLIM). FLIM analysis was per-
formed with SPCImage software (Becker & Hickl GmbH) as reported previ-
ously (Lleres et al., 2007). To restrict the lifetime measurements to the 
junctions, each straight cell–cell contact, regardless of signal intensity of 
the probe at the membrane, was manually selected. A bi-exponential fluor-
escence decay fitting was applied and the mean FRET efficiency per con-
tact was calculated by the equation FRET efficiency = 1 – da/d, where da 
is the lifetime of donor (GFP) interacting with acceptor (RFP) molecules and 
d is GFP lifetime in the absence of acceptor (GFP-Rac control).
F-actin analyses
For  F-actin  clustering  experiments,  latex  beads  (15  µm;  Polysciences) 
were  coated  with  a  monoclonal  anti–E-cadherin  antibody  or  bovine   
serum albumin (Braga et al., 1997; Betson et al., 2002). Attached beads 
were scored for actin recruitment when more than three distinct dots of   
F-actin were visible around the beads and expressed as a percentage of 
total attached beads. Around 30% of the few BSA-coated beads able to 
attach to keratinocytes showed some weak phalloidin staining (negative 
or nonspecific binding).
In  low  speed  actin  cosedimentation  assays,  monomeric  G-actin   
(7 µM final, rabbit skeletal muscle) was polymerized into F-actin by incuba-
tion for 25 min at RT with G-buffer (2 mM Tris HCl, pH 7.5, 2 mM CaCl2, 
200 mM KCl, 0.2 mM ATP, 0.5 mM dithiothreitol). Purified proteins (1 µM 
final) and MgCl2 (2 mM final) were then added to the F-actin solution and 
incubated for 20 min at 4°C with rotation. Samples were then centrifuged 
(8,800 g, 10 min, RT). Short filaments and monomeric actin were present 
in supernatant whereas resulting pellet containing long filaments and bun-
dles was washed twice in G-buffer with 2 mM MgCl2 (100,000 g, 20 min, 
RT). Equivalent amounts of the resulting fractions were analyzed by Coo-
massie blue staining.
F-actin negative staining (Bailly et al., 2001) was performed with 
the following modifications: G-actin (5 µM, in G-buffer) was polymerized 
for 50 min at RT by the addition of 50 mM KCl, 2 mM MgCl2, and 10 mM 
Pipes, pH 7.0 in the absence or presence of Ajuba PreLIM domain (2 µM), 
or -catenin (1.8 µM). Polymerization mixtures were diluted (1:10) in the 
same buffer, blotted on carbon-coated grids, and negatively stained with 
1% uranyl acetate (Bailly et al., 2001). Samples were imaged using a trans-
mission electron microscope (model 1010; JEOL). Similar co-sedimentation of 
F-actin was obtained when the proteins were incubated for 20 min with 
preformed actin filaments.
PAK1 kinase assays
Recombinant PAK1 kinase domain was incubated with 10 µCi -[
32P]ATP 
(PerkinElmer) and different GST fusion proteins (0.4 nmol) trapped on 
glutathione–Sepharose beads in phosphorylation buffer (50 mM Hepes, 
pH 7.3, 10 mM MgCl2, 10 mM NaF, and 2 mM MnCl2) containing   
40 µM cold ATP. After 5 min incubation at 30°C and washing in phos-
phorylation buffer, Laemmli buffer was added to the samples. Proteins 
were separated in SDS-PAGE gel and phosphorylation was visualized by 
autoradiography. Ajuba phospho-peptides were identified by mass spec-
troscopy  commercially  (FingerPrints  Proteomics  Facility,  University  of 
Dundee, Dundee, UK).
For kinase assays on immunoprecipitated PAK1, cells treated with 
IPA3 or PIR-3.5 were lysed in ice-cold buffer (50 mM Hepes, pH 7.3, 
150 mM NaCl, 15 mM NaF, 10% glycerol, 1% Triton X-100, 20 mM   
-glycerophosphate, 1 mM orthovanadate, 1 mM phenylmethylsulfonyl fluo-
ride [PMSF], and 1 µg/ml leupeptin). Lysates were precleared by centrifu-
gation at 8,800 g for 5 min at 4°C and immunoprecipitated with 2 µg of 
PAK1 antibody for 2 h at 4°C. Precipitates were washed three times in   
50 mM Hepes, pH 7.3, 150 mM NaCl, 15 mM NaF, 2 mM EDTA, 10% 
glycerol, and 0.2% Triton X-100, and once with phosphorylation buffer. 
PAK1 immunoprecipitates were subjected to in vitro kinase assays with the 
following modifications: samples were incubated with 20 µCi -[
32P]ATP 
(PerkinElmer) in phosphorylation buffer containing 20 µM cold ATP. After 
10 min incubation, Laemmli buffer was added to samples and proteins 
were separated and phosphorylation was visualized as described above.
Quantifications
For aggregation assays, the area of aggregates across six drops per sam-
ple and per experiment was determined using ImageJ software. After me-
chanical disruption, all disaggregates in a drop were imaged. Aggregates 
of less than three cells were excluded from the quantification. Results are 
depicted as mean area of each aggregate after dissociation, normalized 
with area of respective aggregates before trituration. For quantification of 
cadherin levels upon detergent extraction, background of images was sub-
tracted using dedicated function in ImageJ. E-cadherin intensity was thresh-
olded in order to mainly select signal at junctions. Area of the resulting 
binary  mask  was  measured  and  divided  by  total  area  of  the  picture   
(in pixel
2) for normalization. Ratio values were expressed relative to con-
trol, which was set as 100%. More than three random fields of view were 
computed per sample and per experiment (n = 3).
For FRAP, fluorescence intensity was measured with ImageJ. To cal-
culate bleaching efficiency, GFP-Rac intensity was measured before and 
immediately after bleaching and normalized to initial levels (nonbleached, 
arbitrarily set as 100%). Values were averaged for each condition across 
different experiments and expressed as bleaching intensity. Fluorescence 
recovery time was assessed by measuring intensity values of bleached   
areas for each time point and correcting for background and acquisition 
bleaching (Goodwin and Kenworthy, 2005). Normalized percentage of 
recovery was plotted against time and half-time of fluorescence recovery 
was deducted from a nonlinear regression analysis (one-phase association 
exponential fitting curve) with GraphPad Prism software.
For live imaging, pixel intensity for each time point was measured 
across cell–cell contact of interest and divided by corresponding whole   
image intensity for photobleaching correction. The integral of the resulting 
curves was computed for each time point, normalized by time-zero values 
and plotted as “intensity at membrane” across time. For quantification of 
protein–protein interactions, X-ray films exposed in the linear range were 
scanned  and  specific  bands  quantified  using  ImageJ.  Values  were  ex-
pressed relative to controls as stated in figure legends. Statistical signifi-
cance was assessed using Student’s t test.
Online supplemental material
Fig. S1 shows the mapping of active Rac binding site on Ajuba. Fig. S2 
shows the kinetics of Rac and Ajuba recruitment to newly formed con-
tacts. Fig. S3 demonstrates the ability of Ajuba to dimerize via interaction 
of the LIM with PreLIM domain. Fig. S4 shows supporting evidence for 
Ajuba as a substrate for PAK1 (alignment of sequences, changes in affin-
ity for active Rac binding, and quantification of relative 
32P incorporation 
on Ajuba). Online supplemental material is available at http://www.jcb 
.org/cgi/content/full/jcb.201107162/DC1.
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